English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Matt Smith | Jan 26, 2016

First PSA campaign for prediabetes set to launch

+ Community
Carol Ostrow | Jan 26, 2016

Autism Speaks board welcomes new president, CEO

+ Technology/Innovation
Matt Smith | Jan 26, 2016

ALS Research Program announces FY2015 award recipients

+ Technology/Innovation
Matt Smith | Jan 26, 2016

MD Anderson Cancer Center to collaborate with Abbvie on cancer research

+ Technology/Innovation
Matt Smith | Jan 26, 2016

Smiles for Life app aids family physicians diagnosing oral issues

+ Regulatory
Kerry Goff | Jan 26, 2016

New Jersey hospital mergers create positive and negative outcomes

+ Technology/Innovation
Kasey Schefflin- Emrich | Jan 26, 2016

Bristol-Myers Squibb recognized for advancing multiple myeloma research

+ Technology/Innovation
Matt Smith | Jan 26, 2016

FDA to review application for Amgen's ABP 501 treatment

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 476
  • 477
  • 478
  • 479
  • 480
  • 481
  • 482
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily